Welcome to FZATA
OVERVIEW
FZata is a pre-clinical stage biotech company with a focus on developing antibody-based therapeutics with our proprietary platforms. FZata has generated a pipeline targeting at gastrointestinal related infectious, inflammatory and metabolic diseases. Our mission is to create innovative medicines that make a real difference to health.
NEWS
Research article on FZ002 was published in Science Translational Medicine
November 6, 2020
More
FZata received SBIR Fast-track grant.
August 1, 2020
More
FZata is spotlighted!
July 31, 2020
More
BioBuzz Newsletter- June 2019
May 27, 2020
More
FZata the Recipient of Two Additional SBIR Grants in 2...
February 8, 2018
More
FZata Honored as Best Life Sciences Company 2017
December 28, 2017
More
Copyright 2021 FZata, Inc. All Rights Reserved